What Is Myocarditis?
Myocarditis occurs when the heart muscle becomes inflamed. It can have many possible causes, including infections and other immune-related conditions.
Following COVID-19 vaccination, reported cases have been uncommon. According to the CDC, they have occurred most frequently in adolescent and young adult males, particularly within a week after a second mRNA vaccine dose. Cases have also been reported in females, older adults, and after other doses.
The FDA has also updated the safety information for mRNA COVID-19 vaccines. Its 2025 labeling update reported an estimated incidence of approximately 8 cases of myocarditis and/or pericarditis per million doses among people ages 6 months through 64 years after the 2023–2024 vaccine formula. Among males ages 12 through 24, the estimated rate was approximately 27 cases per million doses.
What Did the Stanford Researchers Discover?
Researchers at Stanford Medicine investigated why vaccination appears to trigger myocarditis in a small number of people.
Their work identified two immune-signaling proteins, CXCL10 and interferon-gamma (IFN-gamma), that appear to play important roles in the inflammatory process observed in their experiments. The researchers studied immune cells, heart-cell models, and animal models to examine how these signals could contribute to cardiac inflammation.
The research suggests that mRNA vaccination can activate certain immune cells, which then communicate with other immune cells through inflammatory signaling. In laboratory and animal experiments, the resulting activity was associated with markers of heart injury.
The findings offer a possible explanation for part of the biological pathway involved in rare vaccine-associated myocarditis. However, research findings from laboratory models do not automatically translate into a treatment or prevention strategy for people.
What About Genistein?
The Stanford researchers also investigated genistein, a naturally occurring compound found in soy.
In their experiments, concentrated genistein preparations reduced some of the inflammatory effects associated with the pathway under investigation. However, the study does not establish that eating soy foods or taking a genistein supplement can prevent myocarditis in vaccinated people.
The researchers themselves described this as an area requiring further investigation. The experimental material was also more concentrated than typical dietary supplements, making it inappropriate to treat the findings as a recommendation for self-treatment.
Does This Mean the Vaccines Are Unsafe?
The available evidence does not support describing mRNA COVID-19 vaccines as broadly unsafe.
At the same time, it is important to acknowledge known risks honestly. Myocarditis and pericarditis are recognized rare adverse events, and U.S. regulators have required warnings about them in vaccine information. Safety monitoring is ongoing.
The CDC also notes that COVID-19 infection itself can cause myocarditis and other cardiovascular complications. When evaluating suspected myocarditis after vaccination, healthcare professionals are advised to consider recent COVID-19 infection and other possible causes as part of the medical assessment.
Why the Research Matters
Understanding how a rare adverse event occurs can help scientists improve vaccines and develop better ways to identify, prevent, or treat complications in the future.
The Stanford study is particularly useful because it moves beyond simply documenting that myocarditis can occur and instead investigates possible biological mechanisms behind the response.
However, scientific research develops over time. A promising laboratory result is not the same thing as a proven therapy, and additional studies are needed before experimental approaches can be considered for routine medical use.
When Should Someone Seek Medical Care?
People who develop symptoms such as chest pain, shortness of breath, or unusual heart palpitations after vaccination should seek medical attention promptly, particularly adolescents and young adults. These symptoms can have many causes, so professional evaluation is important rather than assuming that they are related to a vaccine.
The Bigger Picture
The discussion surrounding vaccine-associated myocarditis requires a balanced view.
The condition is real and has been recognized by health authorities, but it is rare. Research such as the Stanford study is helping scientists understand why it may occur in a small subset of people.
At the same time, these findings should not be presented as proof of a universal mechanism, a newly discovered widespread danger, or a reason to use unproven supplements or treatments.
As researchers continue studying the immune pathways involved, the goal is straightforward: better understand rare complications while improving the safety and effectiveness of future vaccines.